Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
📰 Original Source
Read full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.